The gp120 surface envelope glycoprotein of HIV-1 (HIV) is the primary target for antibodies that neutralize HIV infection in vitro[1], and passive transfer of HIV gp120-specific antibodies confers protection from HIV and chimeric simian-human immune deficiency virus (SHIV) challenge in several animal models [2]–[8]. This evidence concerns the gene ITIH4 and HIV infectious disease.